Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma, Recurrent”

370 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 370 results

Testing effectiveness (Phase 2)Study completedNCT00022620
What this trial is testing

Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT03884101
What this trial is testing

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 842
Not applicableLooking for participantsNCT07631572
What this trial is testing

Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer

Who this might be right for
Gynecologic Cancer
Denise Fabian 10
Testing effectiveness (Phase 2)Study completedNCT01397877
What this trial is testing

GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
ARCAGY/ GINECO GROUP 24
Not applicableEnded earlyNCT00669422
What this trial is testing

ChemoFx® PRO - A Post-Market Data Collection Study

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Precision Therapeutics 2,756
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00377520
What this trial is testing

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
NeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more
Eli Lilly and Company 27
Not applicableEnrolling By InvitationNCT07594327
What this trial is testing

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Who this might be right for
Cervical CancersVaginal CancersVulvar Cancers+2 more
Tampere University Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Large-scale testing (Phase 3)Ended earlyNCT06321068
What this trial is testing

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Who this might be right for
Endometrial Cancer
Bio-Thera Solutions 5
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT05156268
What this trial is testing

Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

Who this might be right for
Endometrial Carcinosarcoma
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01164150
What this trial is testing

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Who this might be right for
Endometrial CancerGastrointestinal ComplicationsRadiation Toxicity+1 more
Cancer Trials Ireland 92
Testing effectiveness (Phase 2)Looking for participantsNCT06917092
What this trial is testing

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Looking for participantsNCT06522828
What this trial is testing

Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

Who this might be right for
Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT04836663
What this trial is testing

TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Who this might be right for
Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Testing effectiveness (Phase 2)Study completedNCT00610740
What this trial is testing

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 18
Not applicableStudy completedNCT01164735
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus CancerStage IV Uterine Corpus Cancer
Gynecologic Oncology Group 169
Next Page